Company Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 04:00:02 2024-12-04 pm EST			After market 04:32:17 pm
203.17 ^USD	+1.29%		202.50	-0.33%

03:26pm	HSBC Adjusts Price Target on IQVIA Holdings to $270 From $290	MT
Dec. 02	Nephron Upgrades IQVIA Holdings to Buy, Price Target is $250	MT

Business description: Iqvia Holdings Inc.

Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows:

- development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes;

- development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers;

- integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc.

Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).

Number of employees: 88,000

Sales by Activity: Iqvia Holdings Inc.

Fiscal Period: December	2019	2020	2021	2022	2023
Research & Development Solutions	5.79B	5.76B	7.56B	7.92B	8.4B
Technology & Analytics Solutions (TAS)	4.49B	4.86B	5.53B	5.75B	5.86B
Contract Sales & Medical Solutions (CSMS)	814M	741M	784M	743M	727M

See all business segments

Geographical breakdown of sales: Iqvia Holdings Inc.

Fiscal Period: December	2019	2020	2021	2022	2023
United States	4.99B	3.98B	4.72B	6.05B	6.74B
Europe and Africa	-	-	4.36B	4.37B	4.46B
Asia-Pacific	2.15B	2.24B	2.67B	3B	2.97B
Americas (Excl. United States)	472M	1.44B	2.13B	996M	809M
Europe and Africa (Excl. United Kingdom)	2.37B	2.56B	-	-	-
United Kingdom	1.11B	1.14B	-	-	-

See all geographic segments

Managers: Iqvia Holdings Inc.

Director	Title	Age	Since
Ari Bousbib CEO	Chief Executive Officer	63	2016-10-02
Ronald Bruehlman DFI	Director of Finance/CFO	63	2020-07-31
Jeffrey Spaeder CTO	Chief Tech/Sci/R&D Officer	-	-
James Berkshire COO	Chief Operating Officer	51	2017-06-30
W. Staub CTO	Chief Tech/Sci/R&D Officer	61	2023-09-24

See IQVIA HOLDINGS INC. governance

Members of the board: Iqvia Holdings Inc.

Manager	Title	Age	Since
John Leonard BRD	Director/Board Member	66	2015-02-04
John Connaughton BRD	Director/Board Member	58	2007-12-31
Ari Bousbib CHM	Chairman	63	2016-10-02
Todd Sisitsky BRD	Director/Board Member	52	2015-12-31
John Danhakl BRD	Director/Board Member	67	2016-10-02
Jim Fasano BRD	Director/Board Member	54	2016-10-02
Colleen Goggins BRD	Director/Board Member	69	2017-07-26
Carol Burt BRD	Director/Board Member	66	2019-02-20
Leslie Morris BRD	Director/Board Member	53	2022-01-23
Sheila Stamps BRD	Director/Board Member	66	2022-01-25

Composition of the Board of Directors

Shareholders: Iqvia Holdings Inc.

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 10.99 %	20,026,230	10.99 %	4 122 M $
BlackRock Advisors LLC 6.434 %	11,728,600	6.434 %	2 414 M $
Harris Associates LP 5.584 %	10,179,104	5.584 %	2 095 M $
GIC Pte Ltd. (Investment Management) 5.009 %	9,130,496	5.009 %	1 879 M $
STATE STREET CORPORATION 4.259 %	7,764,688	4.259 %	1 598 M $

List of IQVIA HOLDINGS INC. shareholders

Company details: Iqvia Holdings Inc.

IQVIA Holdings, Inc.

2400 Ellis Road

27703, Durham

+919 998 2000

http://www.iqvia.com

Group companies: Iqvia Holdings Inc.

Name	Category and Sector
Aecio IT Solutions India Pvt Ltd.
IQVIA Consulting & Information Services India Pvt Ltd. IQVIA Consulting & Information Services India Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2003, IQVIA Consulting & Information Services India Pvt Ltd. is a subsidiary of IQVIA, Inc. that provides consultancy services for the pharmaceutical sector. The company is based in Mumbai, India.	Miscellaneous Commercial Services
IQVIA RDS Italy Srl IQVIA RDS Italy Srl Miscellaneous Commercial ServicesCommercial Services Part of IQVIA Holdings, Inc., IQVIA RDS Italy Srl is a company based in Milan, Italy that offers comprehensive and flexible solutions to help life sciences organizations drive healthcare forward and get the right treatments to patients faster. The Italian company provides innovative pharmacovigilance solutions powered by the IQVIA core, which includes integrated, scalable technologies combined with data, advanced analytics, and deep domain expertise. The company's solutions include dynamic monitoring of structured and unstructured data, single platform source data verification, enablement of decentralized trials, intuitive and automated functionality to improve data quality, audit-ready clinical trials, stronger partnerships between subjects, sites, and sponsors, and interoperable solutions that connect with internal systems and their suite of products. Additionally, IQVIA RDS Italy offers expertise across the generics lifecycle to navigate the complex patent landscape and maximize opportunity.	Miscellaneous Commercial Services
IMS Software Services Ltd.
IQVIA AG (Basal Branch) IQVIA AG (Basal Branch) Data Processing ServicesTechnology Services Part of IQVIA Holdings, Inc., IQVIA AG (Basal Branch) provides data collection and utilization services. The company is based in Cham, Switzerland.	Data Processing Services

See all subsidiaries

Other Biotechnology & Medical Research

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
IQVIA HOLDINGS INC.	+1.09%	+0.76%	-6.16%	-22.86%	36.41B
LONZA GROUP AG	+0.65%	+2.21%	+60.07%	-25.18%	42.79B
CELLTRION, INC.	-2.09%	+4.21%	+12.20%	-7.78%	27.1B
ICON PUBLIC LIMITED COMPANY	+1.41%	+1.59%	-18.90%	-18.69%	17.58B
UNITED THERAPEUTICS CORPORATION	+0.96%	-1.58%	+55.10%	+97.19%	16.46B
MODERNA, INC.	-1.57%	-3.44%	-47.54%	-84.21%	16.39B
BIO-TECHNE CORPORATION	+0.83%	+0.84%	+16.41%	-35.06%	11.92B
MEDPACE HOLDINGS, INC.	+1.78%	+1.91%	+23.58%	+68.52%	10.52B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.08%	-0.21%	-0.72%	-43.32%	10.19B
QIAGEN N.V.	+0.90%	-0.39%	+1.84%	-20.81%	9.62B
Average	+0.37%	-0.22%	+9.59%	-9.22%	19.9B
Weighted average by Cap.	+0.29%	-0.51%	+14.71%	-12.90%